11.285 USD
+0.14 (+1.3%)
Last: Feb 2, 2026, 11:00 AM
IART gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 186 industry peers in the Health Care Equipment & Supplies industry. There are concerns on the financial health of IART while its profitability can be described as average. IART is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
- IART had positive earnings in the past year.
- In the past year IART had a positive cash flow from operations.
- Of the past 5 years IART 4 years were profitable.
- Each year in the past 5 years IART had a positive operating cash flow.
1.2 Ratios
- IART has a Return On Assets (-13.58%) which is in line with its industry peers.
- IART has a Return On Equity (-47.74%) which is comparable to the rest of the industry.
- With a decent Return On Invested Capital value of 4.27%, IART is doing good in the industry, outperforming 74.73% of the companies in the same industry.
- Measured over the past 3 years, the Average Return On Invested Capital for IART is below the industry average of 8.81%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -13.58% | ||
| ROE | -47.74% | ||
| ROIC | 4.27% |
ROA(3y)2.09%
ROA(5y)2.89%
ROE(3y)4.61%
ROE(5y)6.54%
ROIC(3y)6.1%
ROIC(5y)6.15%
1.3 Margins
- IART's Operating Margin of 10.22% is fine compared to the rest of the industry. IART outperforms 79.03% of its industry peers.
- In the last couple of years the Operating Margin of IART has declined.
- IART has a Gross Margin (57.21%) which is in line with its industry peers.
- In the last couple of years the Gross Margin of IART has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 10.22% | ||
| PM (TTM) | N/A | ||
| GM | 57.21% |
OM growth 3Y-14.31%
OM growth 5Y-7.91%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.19%
GM growth 5Y-1.66%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), IART is destroying value.
- The number of shares outstanding for IART has been reduced compared to 1 year ago.
- Compared to 5 years ago, IART has less shares outstanding
- IART has a worse debt/assets ratio than last year.
2.2 Solvency
- IART has an Altman-Z score of 1.22. This is a bad value and indicates that IART is not financially healthy and even has some risk of bankruptcy.
- IART's Altman-Z score of 1.22 is in line compared to the rest of the industry. IART outperforms 52.69% of its industry peers.
- IART has a Debt/Equity ratio of 1.73. This is a high value indicating a heavy dependency on external financing.
- With a Debt to Equity ratio value of 1.73, IART is not doing good in the industry: 79.57% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.73 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.22 |
ROIC/WACC0.56
WACC7.6%
2.3 Liquidity
- A Current Ratio of 3.14 indicates that IART has no problem at all paying its short term obligations.
- Looking at the Current ratio, with a value of 3.14, IART is in line with its industry, outperforming 58.60% of the companies in the same industry.
- A Quick Ratio of 1.80 indicates that IART should not have too much problems paying its short term obligations.
- IART has a Quick ratio of 1.80. This is comparable to the rest of the industry: IART outperforms 49.46% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.14 | ||
| Quick Ratio | 1.8 |
3. Growth
3.1 Past
- IART shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -4.44%.
- Measured over the past years, IART shows a decrease in Earnings Per Share. The EPS has been decreasing by -1.35% on average per year.
- Looking at the last year, IART shows a small growth in Revenue. The Revenue has grown by 4.99% in the last year.
- The Revenue has been growing slightly by 1.20% on average over the past years.
EPS 1Y (TTM)-4.44%
EPS 3Y-6.97%
EPS 5Y-1.35%
EPS Q2Q%31.71%
Revenue 1Y (TTM)4.99%
Revenue growth 3Y1.45%
Revenue growth 5Y1.2%
Sales Q2Q%5.57%
3.2 Future
- The Earnings Per Share is expected to grow by 2.68% on average over the next years.
- IART is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.39% yearly.
EPS Next Y-12.33%
EPS Next 2Y-3.22%
EPS Next 3Y1.53%
EPS Next 5Y2.68%
Revenue Next Year1.09%
Revenue Next 2Y1.9%
Revenue Next 3Y2.45%
Revenue Next 5Y2.39%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 4.76, the valuation of IART can be described as very cheap.
- 98.92% of the companies in the same industry are more expensive than IART, based on the Price/Earnings ratio.
- IART's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.32.
- A Price/Forward Earnings ratio of 4.71 indicates a rather cheap valuation of IART.
- IART's Price/Forward Earnings ratio is rather cheap when compared to the industry. IART is cheaper than 99.46% of the companies in the same industry.
- When comparing the Price/Forward Earnings ratio of IART to the average of the S&P500 Index (25.57), we can say IART is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 4.76 | ||
| Fwd PE | 4.71 |
4.2 Price Multiples
- Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of IART indicates a rather cheap valuation: IART is cheaper than 95.70% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 7.51 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-3.22%
EPS Next 3Y1.53%
5. Dividend
5.1 Amount
- IART does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
INTEGRA LIFESCIENCES HOLDING / IART FAQ
Can you provide the ChartMill fundamental rating for INTEGRA LIFESCIENCES HOLDING?
ChartMill assigns a fundamental rating of 4 / 10 to IART.
What is the valuation status for IART stock?
ChartMill assigns a valuation rating of 6 / 10 to INTEGRA LIFESCIENCES HOLDING (IART). This can be considered as Fairly Valued.
What is the profitability of IART stock?
INTEGRA LIFESCIENCES HOLDING (IART) has a profitability rating of 4 / 10.
What is the financial health of INTEGRA LIFESCIENCES HOLDING (IART) stock?
The financial health rating of INTEGRA LIFESCIENCES HOLDING (IART) is 3 / 10.